Jason Butler
Stock Analyst at Citizens JMP
(4.84)
# 423
Out of 4,966 analysts
717
Total ratings
51.8%
Success rate
19.6%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Reiterated: Buy | $932 → $1,200 | $984.39 | +21.90% | 44 | Aug 18, 2026 | |
| LONA LeonaBio | Reiterated: Buy | $18 → $17 | $6.92 | +145.66% | 36 | Aug 17, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $96 → $110 | $73.77 | +49.11% | 63 | Aug 7, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $92 → $93 | $107.20 | -13.25% | 49 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $25 → $28 | $12.01 | +133.14% | 11 | Aug 6, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $35 → $36 | $27.83 | +29.36% | 49 | Aug 5, 2026 | |
| RZLT Rezolute | Upgraded: Buy | $11 | $4.22 | +160.66% | 33 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $131 → $187 | $118.64 | +57.62% | 14 | Jun 2, 2026 | |
| GHRS GH Research | Reiterated: Buy | $42 → $39 | $27.20 | +43.38% | 24 | May 15, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $62 → $55 | $16.12 | +241.19% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $6.85 | +60.58% | 49 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $20 | $8.87 | +125.48% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $4.30 | +225.38% | 19 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $18 | $3.40 | +428.66% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $10 | $4.08 | +145.10% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $7.06 | +169.12% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 → $80 | $43.62 | +83.40% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $12 | $4.78 | +151.05% | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $7.83 | n/a | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $38 | $21.24 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0004 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0004 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1804 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $29.55 | n/a | 8 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.79 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.69 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $70 | $79.60 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.92 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.82 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $5.09 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.08 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $281.21 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.75 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $37.55 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $11.55 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.78 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.51 | n/a | 1 | Mar 26, 2013 |
argenx SE
Aug 18, 2026
Reiterated: Buy
Price Target: $932 → $1,200
Current: $984.39
Upside: +21.90%
LeonaBio
Aug 17, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $6.92
Upside: +145.66%
Cytokinetics
Aug 7, 2026
Reiterated: Buy
Price Target: $96 → $110
Current: $73.77
Upside: +49.11%
Halozyme Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $92 → $93
Current: $107.20
Upside: -13.25%
Zevra Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $12.01
Upside: +133.14%
ACADIA Pharmaceuticals
Aug 5, 2026
Reiterated: Buy
Price Target: $35 → $36
Current: $27.83
Upside: +29.36%
Rezolute
Jun 3, 2026
Upgraded: Buy
Price Target: $11
Current: $4.22
Upside: +160.66%
ABIVAX Société Anonyme
Jun 2, 2026
Reiterated: Buy
Price Target: $131 → $187
Current: $118.64
Upside: +57.62%
GH Research
May 15, 2026
Reiterated: Buy
Price Target: $42 → $39
Current: $27.20
Upside: +43.38%
Avalo Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $62 → $55
Current: $16.12
Upside: +241.19%
May 14, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $6.85
Upside: +60.58%
May 8, 2026
Reiterated: Buy
Price Target: $19 → $20
Current: $8.87
Upside: +125.48%
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $4.30
Upside: +225.38%
Mar 26, 2026
Reiterated: Buy
Price Target: $19 → $18
Current: $3.40
Upside: +428.66%
Feb 26, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $4.08
Upside: +145.10%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $7.06
Upside: +169.12%
Nov 7, 2025
Reiterated: Buy
Price Target: $77 → $80
Current: $43.62
Upside: +83.40%
Oct 9, 2025
Reiterated: Buy
Price Target: $9 → $12
Current: $4.78
Upside: +151.05%
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $7.83
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $42 → $38
Current: $21.24
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.1804
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $29.55
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $6.79
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.69
Upside: n/a
Jan 9, 2020
Reiterated: Buy
Price Target: $58 → $70
Current: $79.60
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.92
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.82
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $5.09
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $3.08
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $281.21
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.75
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $37.55
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $11.55
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $15.78
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $1.51
Upside: n/a